Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
By L. Markowitz, Eileen F. Dunne, Monal J Saraiya, H. Chesson, Curtis Cr, J. Gee, J. Bocchini, E. Unger. MMWR Recommendations and Reports, 2014
940 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/3642af8cc557672ed88b4011cbdd29452ad4830a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- K. Workowski
- G. Bolan
- W. Williams
- Peter G. Szilagyi
- N. Nelson
- P. Lu
- A. O’Halloran
- A. Rodriguez-Lainz
Citations in the corpus
- Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices (2019, background): “HPV vaccination for adolescents has been routinely recommended for females since 2006 and for males since 2011 (1).”
- Sexually Transmitted Diseases Treatment Guidelines, 2015 (2015, background): “For girls, either vaccine is recommended routinely at ages 11–12 years and can be administered beginning at 9 years of age (16); girls and women aged 13–26 years who have not started or completed the vaccine series should receive the vaccine.”
- Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. (2016, background): “Although vaccination coverage has increased since a licensed HPV vaccine has been available and recommended by ACIP, many adolescent and young adult females remain unvaccinated and vulnerable to develop cancers that safe, effective HPV vaccines can prevent (51).”